InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
2 hedge funds and large institutions have $145K invested in InspireMD, Inc. Warrants in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
44% less capital invested
Capital invested by funds: $258K → $145K (-$113K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$300 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$625 |
NSPRW Hedge Fund Activity: Q2 2017 in Review
2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q2 2017, worth a combined $145K — down 44% from $258K a quarter earlier.
Fund positioning in NSPRW was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $300. The largest seller was Sabby Management, cutting an estimated $625.
- 2 institutional investors held InspireMD, Inc. Warrants (NSPRW) as of Q2 2017, unchanged from Q1 2017.
- Funds reported $145K of InspireMD, Inc. Warrants stock for Q2 2017, down 44% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q2 2017 and 0 closed out.
- The largest InspireMD, Inc. Warrants buyer in Q2 2017 was UBS Group, an estimated $300 added.
- The largest InspireMD, Inc. Warrants seller in Q2 2017 was Sabby Management, an estimated $625 sold.
Based on aggregated 13F filings for Q2 2017.